nach oben

International Orthopaedics

Erschienen in:

18.01.2019 | Original Paper

Two-stage hip revision arthroplasty for periprosthetic joint infection without the use of spacer or cemented implants

verfasst von: Yves Gramlich, Paul Hagebusch, Philipp Faul, Alexander Klug, Gerhard Walter, Reinhard Hoffmann

Erschienen in: International Orthopaedics | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction

There is no gold standard for performing a two-stage exchange arthroplasty to treat periprosthetic joint infection (PJI). The use of spacers and the anchorage principles of the revision prosthesis remain controversial. Herein, we report the success rate of a two-stage total hip replacement procedure without using a spacer and only pressfit cementless implants.

Methods

Between 2009 and 2015, 57 patients with chronic late-onset PJI were treated using a two-stage prostheses exchange without spacer. The average age was 66.7 years (47–83 years). The mean follow-up was 53.9 ± 25 months. Treatment included microbiologic diagnostics and a high-efficiency antimicrobial therapy in between the operations for six weeks and a two week antibiotic-free interval before reimplantation of the cementless prostheses. After implantation, antibiotics were stopped. This study was approved by the institutional review board.

Results

Ninety-six percent of the patients had prior unsuccessful PJI treatment in other hospitals. The most common microorganism was Staphylococcus epidermidis (50.9%), followed by Propionibacterium acnes (17.5%) and Staphylococcus aureus (14%). In 42.1% cases, mixed infections were found. All patients could be treated using a cementless implant. In 91.2%, PJI remission was achieved, while 8.6% had chronic PJI with implant retention. Overall, nine prostheses (15.8%) were replaced owing to ongoing PJI or fractures. Mean modified Harris Hip Score was 60.85 (range: 22–88). None of the patients died.

Conclusion

We demonstrated a high success rate for two-stage exchange of infected total hip arthroplasty. Spacer-free treatment does not negatively affect success rate or function. Implantation of an uncemented pressfit prosthesis was possible in all patients.

Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J (2012) Economic burden of periprosthetic joint infection in the United States. J Arthroplast 27(8 Suppl):61–65CrossRef

Kapadia BH, Banerjee S, Cherian JJ, Bozic KJ, Mont MA (2016) The economic impact of Periprosthetic infections after total hip arthroplasty at a specialized tertiary-care center. J Arthroplast. https://doi.org/10.1016/j.arth.2016.01.021 PubMedCrossRef

Kapadia BH, Berg RA, Daley JA, Fritz J, Bhave A, Mont MA (2016) Periprosthetic joint infection. Lancet 387(10016):386–394PubMedCrossRef

Osmon D, Berbari E, Berendt A, Lew D, Zimmerli W, Steckelberg J, Rao N, Hanssen A, Wilson W (2013) Infectious diseases society of a: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 56(1):e1–e25PubMedCrossRef

Jung J, Schmid NV, Kelm J, Schmitt E, Anagnostakos K (2009) Complications after spacer implantation in the treatment of hip joint infections. Int J Med Sci 6(5):265PubMedPubMedCentralCrossRef

Ma D, Shanks RM, Davis CM III, Craft DW, Wood TK, Hamlin BR, Urish KL (2018) Viable bacteria persist on antibiotic spacers following two-stage revision for periprosthetic joint infection. J Orthop Res 36(1):452–458PubMed

Neut D, van de Belt H, Stokroos I, van Horn JR, van der Mei HC, Busscher HJ (2001) Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. J Antimicrob Chemother 47(6):885–891PubMedCrossRef

DiCicco M, Duong T, Chu A, Jansen SA (2003) Tobramycin and gentamycin elution analysis between two in situ polymerizable orthopedic composites. J Biomed Mater Res B Appl Biomater 65(1):137–149. https://doi.org/10.1002/jbm.b.10528 CrossRefPubMed

Gramlich Y (2018) Procedure for single stage implant retention for chronic periprosthetic infection using topical degradable calcium-based antibiotics. Int Orthop. https://doi.org/10.1007/s00264-018-4066-9 PubMedCrossRef

10.

Gramlich Y, Walter G, Gils J, Hoffmann R (2017) Early results of adjuvant topical treatment of recurrent osteomyelitis with absorbable antibiotic carriers. Z Orthop Unfall 12(10):0042–112228

11.

Fleiter N, Walter G, Bosebeck H, Vogt S, Buchner H, Hirschberger W, Hoffmann R (2014) Clinical use and safety of a novel gentamicin-releasing resorbable bone graft substitute in the treatment of osteomyelitis/osteitis. Bone Joint Res 3(7):223–229PubMedPubMedCentralCrossRef

12.

Gromov K, Pedersen AB, Overgaard S, Gebuhr P, Malchau H, Troelsen A (2015) Do Rerevision rates differ after first-time revision of primary THA with a cemented and cementless femoral component? Clin Orthop Relat Res 473(11):3391–3398PubMedPubMedCentralCrossRef

13.

Mäkelä KT, Matilainen M, Pulkkinen P, Fenstad AM, Havelin L, Engesaeter L, Furnes O, Pedersen AB, Overgaard S, Kärrholm J (2014) Failure rate of cemented and uncemented total hip replacements: register study of combined Nordic database of four nations. BMJ 348:f7592PubMedCrossRef

14.

Maggs J, Wilson M (2017) The relative merits of cemented and uncemented prostheses in total hip arthroplasty. Indian J Orthop 51(4):377–385PubMedPubMedCentralCrossRef

15.

Dohmae Y, Bechtold JE, Sherman RE, Puno RM, Gustilo RB (1988) Reduction in cement-bone interface shear strength between primary and revision arthroplasty. Clin Orthop Relat Res (236):214–220

16.

Schinsky MF, Della Valle CJ, Sporer SM, Paprosky WG (2008) Perioperative testing for joint infection in patients undergoing revision total hip arthroplasty. J Bone Joint Surg Am 90(9):1869–1875PubMedCrossRef

17.

Gehrke T, Parvizi J (2014) Proceedings of the international consensus meeting on periprosthetic joint infection. J Arthroplast 29(2):4CrossRef

18.

Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, Garvin KL, Mont MA, Wongworawat MD, Zalavras CG (2011) New definition for periprosthetic joint infection: from the workgroup of the musculoskeletal infection society. Clin Orthop Relat Res 469(11):2992–2994. https://doi.org/10.1007/s11999-011-2102-9 CrossRefPubMedPubMedCentral

19.

Zimmerli W, Trampuz A, Ochsner PE (2004) Prosthetic-joint infections. N Engl J Med 351(16):1645–1654PubMedCrossRef

20.

Tande AJ, Gomez-Urena EO, Berbari EF, Osmon DR (2017) Management of prosthetic joint infection. Infect Dis Clin N Am 31(2):237–252CrossRef

21.

Bejon P, Berendt A, Atkins B, Green N, Parry H, Masters S, McLardy-Smith P, Gundle R, Byren I (2010) Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology. J Antimicrob Chemother 65(3):569–575PubMedPubMedCentralCrossRef

22.

Frommelt L (2004) Guidelines on antimicrobial therapy in situations of periprosthetic THR infection. Orthopade 33(7):822–828. https://doi.org/10.1007/s00132-004-0677-5 CrossRefPubMed

23.

Tande AJ, Patel R (2014) Prosthetic joint infection. Clin Microbiol Rev 27(2):302–345PubMedPubMedCentralCrossRef

24.

Tice AD, Rehm SJ, Dalovisio JR, Bradley JS, Martinelli LP, Graham DR, Gainer RB, Kunkel MJ, Yancey RW, Williams DN (2004) Practice guidelines for outpatient parenteral antimicrobial therapy. Clin Infect Dis 38(12):1651–1671PubMedCrossRef

25.

Gramlich Y, Walter G, Klug A, Harbering J, Kemmerer M, Hoffmann R (2018) Procedure for single-stage implant retention for chronic periprosthetic infection using topical degradable calcium-based antibiotics. Int Orthop:1–8. https://doi.org/10.1007/s00264-018-4066-9 PubMedCrossRef

26.

Nilsdotter A, Bremander A (2011) Measures of hip function and symptoms: Harris hip score (HHS), hip disability and osteoarthritis outcome score (HOOS), Oxford hip score (OHS), Lequesne index of severity for osteoarthritis of the hip (LISOH), and American Academy of Orthopedic Surgeons (AAOS) hip and knee questionnaire. Arthritis Care Res 63(S11):S200–S207CrossRef

27.

Edwards PK, Queen RM, Butler RJ, Bolognesi MP, Lowry Barnes C (2016) Are range of motion measurements needed when calculating the Harris hip score? J Arthroplast 31(4):815–819CrossRef

28.

Wang J, Wang Q, Shen H, Zhang X (2018) Comparable outcome of culture-negative and culture-positive periprosthetic hip joint infection for patients undergoing two-stage revision. Int Orthop 42(3):469–477PubMedCrossRef

29.

Renz N, Trampuz A (2015) Periprothetische Infektionen: aktueller Stand der Diagnostik und Therapie. Orthopädie & Rheuma 18(6):20–28CrossRef

30.

Giulieri SG, Graber P, Ochsner PE, Zimmerli W (2004) Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection 32(4):222–228PubMedCrossRef

31.

Pulcini C, Couadau T, Bernard E, Lorthat-Jacob A, Bauer T, Cua E, Mondain V, Chichmanian R-M, Dellamonica P, Roger P-M (2008) Adverse effects of parenteral antimicrobial therapy for chronic bone infections. Eur J Clin Microbiol Infect Dis 27(12):1227–1232PubMedCrossRef

32.

Nguyen S, Robineau O, Titecat M, Blondiaux N, Valette M, Loiez C, Beltrand E, Migaud H, Senneville E (2015) Influence of daily dosage and frequency of administration of rifampicin–levofloxacin therapy on tolerance and effectiveness in 154 patients treated for prosthetic joint infections. Eur J Clin Microbiol Infect Dis 34(8):1675–1682PubMedCrossRef

33.

Valour F, Karsenty J, Bouaziz A, Ader F, Tod M, Lustig S, Laurent F, Ecochard R, Chidiac C, Ferry T (2014) Antimicrobial-related severe adverse events during treatment of bone and joint infection due to methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 58(2):746–755PubMedPubMedCentralCrossRef

34.

Mabry TM, Hanssen AD (2007) Articulating antibiotic spacers: a matter of personal preference. Orthopedics 30(9):783–785PubMedCrossRef

35.

Bloomfield MR, Klika AK, Barsoum WK (2010) Antibiotic-coated spacers for total hip arthroplasty infection. Orthopedics 33(9):649. https://doi.org/10.3928/01477447-20100722-21

36.

Ferguson JY, Dudareva M, Riley ND, Stubbs D, Atkins BL, McNally MA (2014) The use of a biodegradable antibiotic-loaded calcium sulphate carrier containing tobramycin for the treatment of chronic osteomyelitis: a series of 195 cases. Bone Joint J 96-B(6):829–836. https://doi.org/10.1302/0301-620X.96B6.32756 CrossRefPubMed

37.

Turner TM, Urban RM, Hall DJ, Chye PC, Segreti J, Gitelis S (2005) Local and systemic levels of tobramycin delivered from calcium sulfate bone graft substitute pellets. Clin Orthop Relat Res 437(1976–2007):97–104

38.

Chang W, Colangeli M, Colangeli S, Di Bella C, Gozzi E, Donati D (2007) Adult osteomyelitis: debridement versus debridement plus Osteoset T pellets. Acta Orthop Belg 73(2):238–243PubMed

39.

Gramlich Y, Walter G, Gils J, Hoffmann R (2017) Early results of adjuvant topical treatment of recurrent osteomyelitis with absorbable antibiotic carriers. Z Orthop Unfall 155(1):35–44PubMedCrossRef

40.

Marczak D, Synder M, Sibiński M, Polguj M, Dudka J, Kowalczewski J (2017) Two stage revision hip arthroplasty in periprosthetic joint infection. Comparison study: with or without the use of a spacer. Int Orthop 41(11):2253–2258PubMedCrossRef

41.

Tikhilov R, Bozhkova S, Denisov A, Labutin D, Shubnyakov I, Razorenov V, Artyukh V, Klitsenko O (2016) Risk factors and a prognostic model of hip periprosthetic infection recurrence after surgical treatment using articulating and non-articulating spacers. Int Orthop 40(7):1381–1387PubMedCrossRef

42.

Cabrita HB, Croci AT, Camargo OP, Lima AL (2007) Prospective study of the treatment of infected hip arthroplasties with or without the use of an antibiotic-loaded cement spacer. Clinics 62(2):99–108PubMedCrossRef

43.

Du YQ, Zhou YG, Hao LB, Wu WM, Ma HY, Zheng C, Piao S, Gao ZS, Sun JY, Wang S (2017) Mechanical complications with self-made, antibiotic-loaded cement articulating spacers in the treatment of the infected hip replacement. Zhongguo Gu Shang 30(5):436–440PubMed

44.

Gomez MM, Tan TL, Manrique J, Deirmengian GK, Parvizi J (2015) The fate of spacers in the treatment of periprosthetic joint infection. J Bone Joint Surg Am 97(18):1495–1502PubMedCrossRef

45.

Kahlenberg CA, Hernandez-Soria A, Cross MB (2017) Poor prognosis of patients treated for Periprosthetic joint infection. HSS J 13(1):96–99PubMedCrossRef

46.

Bordini B, Stea S, Castagnini F, Busanelli L, Giardina F, Toni A (2018) The influence of bearing surfaces on periprosthetic hip infections: analysis of thirty nine thousand, two hundred and six cementless total hip arthroplasties. Int Orthop 11(10):018–4097

47.

Wirtz D, Niethard F (1997) Etiology, diagnosis and therapy of aseptic hip prosthesis loosening--a status assessment. Z Orthop Grenzgeb 135(4):270–280CrossRef

48.

Masri BA, Panagiotopoulos KP, Greidanus NV, Garbuz DS, Duncan CP (2007) Cementless two-stage exchange arthroplasty for infection after total hip arthroplasty. J Arthroplast 22(1):72–78CrossRef

Titel: Two-stage hip revision arthroplasty for periprosthetic joint infection without the use of spacer or cemented implants
verfasst von: Yves Gramlich
Paul Hagebusch
Philipp Faul
Alexander Klug
Gerhard Walter
Reinhard Hoffmann
Publikationsdatum: 18.01.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: International Orthopaedics / Ausgabe 11/2019
Print ISSN: 0341-2695
Elektronische ISSN: 1432-5195
DOI: https://doi.org/10.1007/s00264-019-04297-y

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Introduction

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2019

Clinical, functional, and isokinetic study of a prospective series of anterior cruciate ligament ligamentoplasty with pedicular hamstrings

Relationship between the incidence of de Quervain’s disease among teenagers and mobile gaming

Diagnosing acute compartment syndrome—where have we got to?

Comorbidity and mortality after hip fracture in nineteen thousand six hundred and eighty two patients aged eighteen to sixty five years in Denmark from 1996 to 2012

Age and “general health”—beside fracture classification—affect the therapeutic decision for geriatric pelvic ring fractures: a German pelvic injury register study